E1	Procedure:T1 Name:T2 Temporality:E33
E3	Procedure:T3 Name:T4
E9	Condition:T9 Name:T10
E11	Procedure:T11 Name:T12
E12	Age:T25 Numeric-Filter:E13
E13	Eq-Comparison:T36 Operator:T13 Value:T26 Temporal-Unit:T27 Value2:T21 Operator2:T14
E15	Eq-Comparison:T38 Operator:T15 Value:T29
E16	Eq-Comparison:T39 Operator:T16 Value:T30
E17	Eq-Comparison:T40 Operator:T17 Value:T31 Unit:T59 Unit2:T60 Unit3:T61
E18	Eq-Comparison:T41 Operator:T18 Unit:T24 Value:T33
E19	Eq-Comparison:T42 Operator:T19 Value:T34 Temporal-Unit:T87
E20	Eq-Comparison:T43 Operator:T20 Value:T35 Temporal-Unit:T103
E21	Eq-Comparison:T44 Temporal-Period:T45
E22	Eq-Comparison:T46 Temporal-Period:T47
E4	Condition:T37 Name:T49 Duration:E7 Acuteness:T50
E7	Eq-Comparison:T51 Operator:T52 Value:T28 Temporal-Unit:T22
E6	Observation:T6 Name:T7
E8	Observation:T53 Name:T54 Numeric-Filter:E15
E10	Observation:T55 Name:T56 Numeric-Filter:E16
E14	Observation:T57 Name:T58 Numeric-Filter:E17
E23	Eq-Comparison:T62 Temporal-Period:T63
E24	Drug:T64 Name:T65 Temporality:E21 Temporality2:E23
E25	Condition:T67 Name:T68
E26	Assertion:T69 Asserted:E25
E27	Condition:T70 Name:T71
E28	Assertion:T72 Asserted:E27 Asserted2:E3
E30	Study:T74 
E32	Study:T76 Study-Of:E1
E33	Eq-Comparison:T77 Temporal-Recency:T78
E35	Eq-Comparison:T80 Value:T32 Temporal-Unit:T23
E37	Observation:T82 Name:T83 Numeric-Filter:E18
E38	Condition:T84 Name:T85 Temporality:E19
E39	Modifier:T86 Modifies:T85
E40	Condition:T88 Name:T89
E42	Procedure:T91 
E43	Modifier:T92 Modifies:T12
E44	Modifier:T93 Modifies:T12
E46	Assertion:T95 Asserted:E42
E47	Drug:T96 Name:T97 Temporality:E20
E48	Drug:T98 Name:T99 Temporality:E20
E49	Drug:T100 Name:T101 Temporality:E20
E51	Condition:T104 Name:T105 Temporality:E22
E52	Drug:T106 Name:T107
E53	Drug:T108 Name:T109
E54	Modifier:T110 Modifies:T109
E55	Modifier:T111 Modifies:T109
E57	Condition:T113 Severity:T114
T1	Procedure 535 549	drug injection
T2	Procedure-Name 535 549	drug injection
T3	Procedure 462 475	contraception
T4	Procedure-Name 462 475	contraception
T5	Life-Stage-And-Gender 36 42	female
T8	Life-Stage-And-Gender 28 32	Male
T9	Condition 813 824	anaphylaxis
T10	Condition-Name 813 824	anaphylaxis
T11	Procedure 699 710	antibiotics
T12	Procedure-Name 699 710	antibiotics
T13	Eq-Operator 52 53	≥
T15	Eq-Operator 189 190	≥
T16	Eq-Operator 209 210	≥
T17	Eq-Operator 233 234	≥
T18	Eq-Operator 591 592	<
T19	Eq-Operator 624 630	within
T20	Eq-Operator 755 761	within
T22	Eq-Temporal-Unit 134 139	years
T23	Eq-Temporal-Unit 508 513	weeks
T24	Eq-Unit 596 598	kg
T25	Age 74 77	age
T26	Eq-Value 54 56	12
T28	Eq-Value 132 133	2
T29	Eq-Value 191 193	16
T30	Eq-Value 211 212	3
T31	Eq-Value 235 237	10
T32	Eq-Value 505 507	12
T33	Eq-Value 593 595	30
T34	Eq-Value 631 632	1
T35	Eq-Value 762 763	1
T36	Eq-Comparison 52 70	≥ 12 to < 18 years
T38	Eq-Comparison 189 193	≥ 16
T39	Eq-Comparison 209 212	≥ 3
T40	Eq-Comparison 233 265	≥ 10% of Body Surface Area (BSA)
T41	Eq-Comparison 591 598	< 30 kg
T42	Eq-Comparison 624 637	within 1 week
T43	Eq-Comparison 755 768	within 1 week
T44	Eq-Comparison 289 296	history
T45	Eq-Temporal-Period 289 296	history
T46	Eq-Comparison 774 781	History
T47	Eq-Temporal-Period 774 781	History
T14	Eq-Operator 57 59	to
T21	Eq-Value 62 64	18
T27	Eq-Temporal-Unit 65 70	years
T37	Condition 91 93	AD
T49	Condition-Name 91 93	AD
T50	Acuteness 83 90	Chronic
T51	Eq-Comparison 123 139	at least 2 years
T52	Eq-Operator 123 131	at least
T6	Observation 145 175	Eczema Area and Severity Index
T7	Observation-Name 145 175	Eczema Area and Severity Index
T53	Observation 177 181	EASI
T54	Observation-Name 177 181	EASI
T55	Observation 199 202	IGA
T56	Observation-Name 199 202	IGA
T57	Observation 218 232	AD involvement
T58	Observation-Name 218 232	AD involvement
T59	Eq-Unit 237 238	%
T60	Eq-Unit 242 259	Body Surface Area
T61	Eq-Unit 261 264	BSA
T62	Eq-Comparison 282 288	recent
T63	Eq-Temporal-Period 282 288	recent
T64	Drug 323 342	topical medications
T65	Drug-Name 323 342	topical medications
T66	Life-Stage-And-Gender 348 353	Women
T67	Condition 357 369	childbearing
T68	Condition-Name 357 369	childbearing
T69	Assertion 370 379	potential
T70	Condition 406 415	abstinent
T71	Condition-Name 406 415	abstinent
T72	Assertion 385 393	agree to
T74	Study 491 496	study
T76	Study 529 534	study
T77	Eq-Comparison 524 528	last
T78	Eq-Temporal-Recency 524 528	last
T80	Eq-Comparison 505 513	12 weeks
T82	Observation 579 590	Body weight
T83	Observation-Name 579 590	Body weight
T84	Condition 614 623	infection
T85	Condition-Name 614 623	infection
T86	Modifier 604 613	Cutaneous
T87	Eq-Temporal-Unit 633 637	week
T88	Condition 645 654	infection
T89	Condition-Name 645 654	infection
T91	Procedure 665 674	treatment
T92	Modifier 688 698	parenteral
T93	Modifier 680 684	oral
T95	Assertion 655 664	requiring
T96	Drug 712 722	antivirals
T97	Drug-Name 712 722	antivirals
T98	Drug 724 738	antiparasitics
T99	Drug-Name 724 738	antiparasitics
T100	Drug 743 754	antifungals
T101	Drug-Name 743 754	antifungals
T103	Eq-Temporal-Unit 764 768	week
T104	Condition 785 801	hypersensitivity
T105	Condition-Name 785 801	hypersensitivity
T106	Drug 832 854	immunoglobulin product
T107	Drug-Name 832 854	immunoglobulin product
T108	Drug 891 910	monoclonal antibody
T109	Drug-Name 891 910	monoclonal antibody
T110	Modifier 874 885	recombinant
T111	Modifier 856 870	plasma-derived
T113	Condition 944 949	issue
T114	Severity 932 943	significant
A1	Life-Stage-And-Gender-Type T5 female
A2	Life-Stage-And-Gender-Type T8 male
A3	Eq-Operator-Value T13 GTEQ
A5	Eq-Operator-Value T15 GTEQ
A6	Eq-Operator-Value T16 GTEQ
A7	Eq-Operator-Value T17 GTEQ
A8	Eq-Operator-Value T18 LT
A9	Eq-Operator-Value T19 LTEQ
A10	Eq-Operator-Value T20 LTEQ
A12	Eq-Temporal-Unit-Value T22 year
A13	Eq-Temporal-Unit-Value T23 week
A14	Eq-Temporal-Period-Value T45 past
A15	Eq-Temporal-Period-Value T47 past
A4	Eq-Operator-Value T14 BETWEEN
A11	Eq-Temporal-Unit-Value T27 year
A16	Eq-Operator-Value T52 GTEQ
A17	Observation-Type-Value E6 clinical-score
A18	Observation-Type-Value E10 clinical-score
A19	Observation-Type-Value E14 measurement
A20	Eq-Temporal-Period-Value T63 recent
A21	Life-Stage-And-Gender-Type T66 female
A22	Assertion-Type-Value E26 hypothetical
A23	Assertion-Type-Value E28 hypothetical
A25	Eq-Temporal-Recency-Value T78 most-recent-time
A27	Observation-Type-Value E37 vital
A28	Eq-Temporal-Unit-Value T87 week
A29	Assertion-Type-Value E46 hypothetical
A30	Eq-Temporal-Unit-Value T103 week
A31	Severity-Value T114 severe
A32	Acuteness-Type-Value T50 chronic
R1	Abbrev-Of Arg1:E8 Arg2:E6
R2	Abbrev-Of Arg1:T61 Arg2:T60
R3	If-Then Arg1:T66 Arg2:E25
R4	If-Then Arg1:E25 Arg2:E27
R5	Using Arg1:E42 Arg2:E11
R6	Treatment-For Arg1:E42 Arg2:E40
R7	Example-Of Arg1:E9 Arg2:E51
R8	Caused-By Arg1:E51 Arg2:E52
R9	Example-Of Arg1:E53 Arg2:E52
R10	Or Arg1:T8 Arg2:T5
R11	Or Arg1:E27 Arg2:E3
R12	During Arg1:E3 Arg2:E30
R13	After Arg1:E35 Arg2:E33
R14	And Arg1:E30 Arg2:E35
R15	Or Arg1:E38 Arg2:E40
R16	Or Arg1:E44 Arg2:E43
R17	Or Arg1:E48 Arg2:E49
R18	Or Arg1:E55 Arg2:E54
R19	Or Arg1:E11 Arg2:E47
R20	Or Arg1:E47 Arg2:E48
